Copyright Reports & Markets. All rights reserved.

Global Aptamer Market Size, Status and Forecast 2021-2027

Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Aptamer Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
    • 1.2.2 DNA-Based Aptamers
    • 1.2.3 RNA-Based Aptamers
  • 1.3 Market by Application
    • 1.3.1 Global Aptamer Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Research and Development
    • 1.3.3 Drug Discovery
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Aptamer Market Perspective (2016-2027)
  • 2.2 Aptamer Growth Trends by Regions
    • 2.2.1 Aptamer Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 Aptamer Historic Market Share by Regions (2016-2021)
    • 2.2.3 Aptamer Forecasted Market Size by Regions (2022-2027)
  • 2.3 Aptamer Industry Dynamic
    • 2.3.1 Aptamer Market Trends
    • 2.3.2 Aptamer Market Drivers
    • 2.3.3 Aptamer Market Challenges
    • 2.3.4 Aptamer Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Aptamer Players by Revenue
    • 3.1.1 Global Top Aptamer Players by Revenue (2016-2021)
    • 3.1.2 Global Aptamer Revenue Market Share by Players (2016-2021)
  • 3.2 Global Aptamer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Aptamer Revenue
  • 3.4 Global Aptamer Market Concentration Ratio
    • 3.4.1 Global Aptamer Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Aptamer Revenue in 2020
  • 3.5 Aptamer Key Players Head office and Area Served
  • 3.6 Key Players Aptamer Product Solution and Service
  • 3.7 Date of Enter into Aptamer Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Aptamer Breakdown Data by Type

  • 4.1 Global Aptamer Historic Market Size by Type (2016-2021)
  • 4.2 Global Aptamer Forecasted Market Size by Type (2022-2027)

5 Aptamer Breakdown Data by Application

  • 5.1 Global Aptamer Historic Market Size by Application (2016-2021)
  • 5.2 Global Aptamer Forecasted Market Size by Application (2022-2027)

6 North America

  • 6.1 North America Aptamer Market Size (2016-2027)
  • 6.2 North America Aptamer Market Size by Type
    • 6.2.1 North America Aptamer Market Size by Type (2016-2021)
    • 6.2.2 North America Aptamer Market Size by Type (2022-2027)
    • 6.2.3 North America Aptamer Market Size by Type (2016-2027)
  • 6.3 North America Aptamer Market Size by Application
    • 6.3.1 North America Aptamer Market Size by Application (2016-2021)
    • 6.3.2 North America Aptamer Market Size by Application (2022-2027)
    • 6.3.3 North America Aptamer Market Size by Application (2016-2027)
  • 6.4 North America Aptamer Market Size by Country
    • 6.4.1 North America Aptamer Market Size by Country (2016-2021)
    • 6.4.2 North America Aptamer Market Size by Country (2022-2027)
    • 6.4.3 United States
    • 6.4.3 Canada

7 Europe

  • 7.1 Europe Aptamer Market Size (2016-2027)
  • 7.2 Europe Aptamer Market Size by Type
    • 7.2.1 Europe Aptamer Market Size by Type (2016-2021)
    • 7.2.2 Europe Aptamer Market Size by Type (2022-2027)
    • 7.2.3 Europe Aptamer Market Size by Type (2016-2027)
  • 7.3 Europe Aptamer Market Size by Application
    • 7.3.1 Europe Aptamer Market Size by Application (2016-2021)
    • 7.3.2 Europe Aptamer Market Size by Application (2022-2027)
    • 7.3.3 Europe Aptamer Market Size by Application (2016-2027)
  • 7.4 Europe Aptamer Market Size by Country
    • 7.4.1 Europe Aptamer Market Size by Country (2016-2021)
    • 7.4.2 Europe Aptamer Market Size by Country (2022-2027)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Aptamer Market Size (2016-2027)
  • 8.2 Asia-Pacific Aptamer Market Size by Type
    • 8.2.1 Asia-Pacific Aptamer Market Size by Type (2016-2021)
    • 8.2.2 Asia-Pacific Aptamer Market Size by Type (2022-2027)
    • 8.2.3 Asia-Pacific Aptamer Market Size by Type (2016-2027)
  • 8.3 Asia-Pacific Aptamer Market Size by Application
    • 8.3.1 Asia-Pacific Aptamer Market Size by Application (2016-2021)
    • 8.3.2 Asia-Pacific Aptamer Market Size by Application (2022-2027)
    • 8.3.3 Asia-Pacific Aptamer Market Size by Application (2016-2027)
  • 8.4 Asia-Pacific Aptamer Market Size by Region
    • 8.4.1 Asia-Pacific Aptamer Market Size by Region (2016-2021)
    • 8.4.2 Asia-Pacific Aptamer Market Size by Region (2022-2027)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Aptamer Market Size (2016-2027)
  • 9.2 Latin America Aptamer Market Size by Type
    • 9.2.1 Latin America Aptamer Market Size by Type (2016-2021)
    • 9.2.2 Latin America Aptamer Market Size by Type (2022-2027)
    • 9.2.3 Latin America Aptamer Market Size by Type (2016-2027)
  • 9.3 Latin America Aptamer Market Size by Application
    • 9.3.1 Latin America Aptamer Market Size by Application (2016-2021)
    • 9.3.2 Latin America Aptamer Market Size by Application (2022-2027)
    • 9.3.3 Latin America Aptamer Market Size by Application (2016-2027)
  • 9.4 Latin America Aptamer Market Size by Country
    • 9.4.1 Latin America Aptamer Market Size by Country (2016-2021)
    • 9.4.2 Latin America Aptamer Market Size by Country (2022-2027)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Aptamer Market Size (2016-2027)
  • 10.2 Middle East & Africa Aptamer Market Size by Type
    • 10.2.1 Middle East & Africa Aptamer Market Size by Type (2016-2021)
    • 10.2.2 Middle East & Africa Aptamer Market Size by Type (2022-2027)
    • 10.2.3 Middle East & Africa Aptamer Market Size by Type (2016-2027)
  • 10.3 Middle East & Africa Aptamer Market Size by Application
    • 10.3.1 Middle East & Africa Aptamer Market Size by Application (2016-2021)
    • 10.3.2 Middle East & Africa Aptamer Market Size by Application (2022-2027)
    • 10.3.3 Middle East & Africa Aptamer Market Size by Application (2016-2027)
  • 10.4 Middle East & Africa Aptamer Market Size by Country
    • 10.4.1 Middle East & Africa Aptamer Market Size by Country (2016-2021)
    • 10.4.2 Middle East & Africa Aptamer Market Size by Country (2022-2027)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 TriLink BioTechnologies
    • 11.1.1 TriLink BioTechnologies Company Details
    • 11.1.2 TriLink BioTechnologies Business Overview
    • 11.1.3 TriLink BioTechnologies Aptamer Introduction
    • 11.1.4 TriLink BioTechnologies Revenue in Aptamer Business (2016-2021)
    • 11.1.5 TriLink BioTechnologies Recent Development
  • 11.2 AptaBharat
    • 11.2.1 AptaBharat Company Details
    • 11.2.2 AptaBharat Business Overview
    • 11.2.3 AptaBharat Aptamer Introduction
    • 11.2.4 AptaBharat Revenue in Aptamer Business (2016-2021)
    • 11.2.5 AptaBharat Recent Development
  • 11.3 SomaLogic
    • 11.3.1 SomaLogic Company Details
    • 11.3.2 SomaLogic Business Overview
    • 11.3.3 SomaLogic Aptamer Introduction
    • 11.3.4 SomaLogic Revenue in Aptamer Business (2016-2021)
    • 11.3.5 SomaLogic Recent Development
  • 11.4 AM Biotechnologies
    • 11.4.1 AM Biotechnologies Company Details
    • 11.4.2 AM Biotechnologies Business Overview
    • 11.4.3 AM Biotechnologies Aptamer Introduction
    • 11.4.4 AM Biotechnologies Revenue in Aptamer Business (2016-2021)
    • 11.4.5 AM Biotechnologies Recent Development
  • 11.5 Aptamer Sciences
    • 11.5.1 Aptamer Sciences Company Details
    • 11.5.2 Aptamer Sciences Business Overview
    • 11.5.3 Aptamer Sciences Aptamer Introduction
    • 11.5.4 Aptamer Sciences Revenue in Aptamer Business (2016-2021)
    • 11.5.5 Aptamer Sciences Recent Development
  • 11.6 Base Pair Biotechnologies
    • 11.6.1 Base Pair Biotechnologies Company Details
    • 11.6.2 Base Pair Biotechnologies Business Overview
    • 11.6.3 Base Pair Biotechnologies Aptamer Introduction
    • 11.6.4 Base Pair Biotechnologies Revenue in Aptamer Business (2016-2021)
    • 11.6.5 Base Pair Biotechnologies Recent Development
  • 11.7 Aptamer Group
    • 11.7.1 Aptamer Group Company Details
    • 11.7.2 Aptamer Group Business Overview
    • 11.7.3 Aptamer Group Aptamer Introduction
    • 11.7.4 Aptamer Group Revenue in Aptamer Business (2016-2021)
    • 11.7.5 Aptamer Group Recent Development
  • 11.8 Aptagen
    • 11.8.1 Aptagen Company Details
    • 11.8.2 Aptagen Business Overview
    • 11.8.3 Aptagen Aptamer Introduction
    • 11.8.4 Aptagen Revenue in Aptamer Business (2016-2021)
    • 11.8.5 Aptagen Recent Development
  • 11.9 Aptus Biotech
    • 11.9.1 Aptus Biotech Company Details
    • 11.9.2 Aptus Biotech Business Overview
    • 11.9.3 Aptus Biotech Aptamer Introduction
    • 11.9.4 Aptus Biotech Revenue in Aptamer Business (2016-2021)
    • 11.9.5 Aptus Biotech Recent Development
  • 11.10 NeoVentures Biotechnology
    • 11.10.1 NeoVentures Biotechnology Company Details
    • 11.10.2 NeoVentures Biotechnology Business Overview
    • 11.10.3 NeoVentures Biotechnology Aptamer Introduction
    • 11.10.4 NeoVentures Biotechnology Revenue in Aptamer Business (2016-2021)
    • 11.10.5 NeoVentures Biotechnology Recent Development
  • 11.11 Ray Biotech
    • 11.11.1 Ray Biotech Company Details
    • 11.11.2 Ray Biotech Business Overview
    • 11.11.3 Ray Biotech Aptamer Introduction
    • 11.11.4 Ray Biotech Revenue in Aptamer Business (2016-2021)
    • 11.11.5 Ray Biotech Recent Development
  • 11.12 Vivonics
    • 11.12.1 Vivonics Company Details
    • 11.12.2 Vivonics Business Overview
    • 11.12.3 Vivonics Aptamer Introduction
    • 11.12.4 Vivonics Revenue in Aptamer Business (2016-2021)
    • 11.12.5 Vivonics Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Aptamer market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Aptamer market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

    Segment by Type
    DNA-Based Aptamers
    RNA-Based Aptamers

    Segment by Application
    Research and Development
    Drug Discovery

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia
    Latin America
    Mexico
    Brazil
    Rest of Latin America
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of MEA

    By Company
    TriLink BioTechnologies
    AptaBharat
    SomaLogic
    AM Biotechnologies
    Aptamer Sciences
    Base Pair Biotechnologies
    Aptamer Group
    Aptagen
    Aptus Biotech
    AM Biotechnologies
    Aptamer Sciences

    Buy now